Biocon Academy Alumni Day Meet throws up insights into future of biotech industry
Over 100 graduates of the Academy attended the Alumni Day celebrations to reminisce and relive the fun days they had spent in…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Home » Latest Updates » Page 265
Browsing Category
Latest Updates
Mankind forays into diagnostics with Pathkind
To invest Rs 305 crores in the new venture which will begin operations from August 2017
US FDA approval for Dupixent, targeted biologic therapy for atopic dermatitis
Dupixent will be available later this week to the US patients suffering from this chronic and debilitating form of eczema
DRL in agreement with Integra LifeSciences
To market and distribute DuraGen Plus and Suturable DuraGen Dural Regeneration in India
Dr Reddy's Laboratories (DRL) and Integra…
Merck advances lab water purification technology with Milli-Q IQ 7000 System
Smaller, ergonomic design reduces waste, increases productivity, accelerates research
Merck announced the global launch of the…
Almirall and Sun Pharma announce regulatory filing of tildrakizumab in Europe
Pivotal Phase 3 data demonstrated potential of Tildrakizumab to offer patients treatment for moderate-to-severe plaque psoriasis…
Aptar Pharma’s multidose ophthalmic squeeze dispenser available in the US
The company is working closely with eye care specialist Allergan to improve patient safety, achieve dosing accuracy and maintain…
SGLT-2 inhibitors significantly reduce death and hospitalisations for heart failure: Astrazeneca…
The study of more than 300,000 patients with type-2 diabetes showed treatment with SGLT-2 inhibitors reduced all-cause mortality…
Divis Labs gets US FDA import alert
The company has announced that it is working with third party consultants to address concerns of USFDA
Piramal buys Mallinckrodt’s pain drug portfolio
Piramal’s critical care business is a global player in the hospital generics segment